Prognosis and survival for salivary gland cancer
If you have salivary gland cancer, you may have questions about your prognosis. A prognosis is the doctor's best estimate of how cancer will affect someone and how it will respond to treatment. Prognosis and survival depend on many factors. Only a doctor familiar with your medical history, the type and stage and other features of the cancer, the treatments chosen and the response to treatment can put all of this information together with survival statistics to arrive at a prognosis.
A prognostic factor is an aspect of the cancer or a characteristic of the person that the doctor will consider when making a prognosis. A predictive factor influences how a cancer will respond to a certain treatment. Prognostic and predictive factors are often discussed together. They both play a part in deciding on a treatment plan and a prognosis.
The following are prognostic and predictive factors for salivary gland cancer.
The stage, especially the tumour (T) category, is the most important prognostic factor for salivary gland cancer. Large tumours and tumours that have grown into tissue around the salivary glands have a less favourable prognosis.
High-grade tumours have a less favourable prognosis than low-grade tumours. This is because high-grade tumours are usually aggressive, which means they tend to grow and spread quickly. They also have a higher risk of coming back (recurring) in other parts of the body such as the lungs or bone.
Type of tumour @(Model.HeadingTag)>
Adenoid cystic carcinoma has the least favourable prognosis of all types of salivary gland cancer. This is because it tends to grow into and along the nerves of the face (perineural invasion). It also tends to come back even many years after first treatment.
American Cancer Society. Salivary Gland Cancer. American Cancer Society; 2014: http://www.cancer.org/cancer/salivaryglandcancer/index.
Garden, A. S . Salivary gland cancer. Gospodarowicz, M. K., O'Sullivan, B., Sobin, L. H., et al. (Eds.). Prognostic Factors in Cancer. 3rd ed. Hoboken, NJ: John Wiley & Sons, Inc; 2006: 10:pp. 113-117.
Iqbal H, Bhatti ABH, Husain R & Jamshed A . Ten year experience with surgery and radiation in the management of malignat major salivary gland tumors. Asian Pacific Journal of Cancer Prevention. National Cancer Center Korea; 2014.
Lee SC . Salivary gland neoplasms. eMedicine.Medscape.com. WebMD LLC; 2013: http://emedicine.medscape.com/article/852373-overview.
Mendenhall WM, Werning JW and Pfister DG . Treatment of head and neck cancer. DeVita VT Jr, Lawrence TS, & Rosenberg SA. Cancer: Principles & Practice of Oncology. 9th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011: 72:729-80.
National Cancer Institute. Salivary Gland Cancer Treatment (PDQ®) Health Professional Version. 2014.